export const hypertrophicCardiomyopathyNonpharmacologicInterventions = {
  title: "Nonpharmacologic Interventions",
  sections: [
    {
      title: "Lifestyle modifications",
      evidenceLevel: "B",
      guidelines: [
        {
          organization: "ACC/AHA/AMSSM/SCMR 2024",
          recommendations: [
            "Offer counseling and comprehensive lifestyle interventions to achieve and maintain weight loss and possibly reduce the risk of developing LVOTO, HF, and AF in patients with HCM and overweight or obesity.",
            "Offer lifestyle modifications and medical therapy for hypertension, with a preference for Î²-blockers and nondihydropyridine CCBs, in patients with obstructive HCM and hypertension."
          ]
        }
      ]
    },
    {
      title: "Physical activity restrictions",
      evidenceLevel: "B",
      guidelines: [
        {
          organization: "ACC/AHA/AMSSM/SCMR 2024",
          recommendations: [
            "Advise practicing mild-to-moderate-intensity recreational exercise to improve cardiorespiratory fitness, physical functioning, and QoL, and for overall health in patients with HCM, in keeping with physical activity guidelines for the general population.",
            "Obtain a comprehensive evaluation and shared decision-making about sports participation with an expert professional for athletes with HCM.",
            "Consider allowing participation in competitive sports of any intensity in genotype-positive, phenotype-negative patients.",
            "Consider advising participation in vigorous recreational activities in patients with HCM after an annual comprehensive evaluation and shared decision-making with an expert professional balancing potential benefits and risks, with this process being repeated annually.",
            "Do not implement universal restriction on vigorous physical activity or competitive sports in most patients with HCM.",
            "Do not perform ICD implantation in patients with HCM for the sole purpose of participation in competitive sports."
          ],
          evidenceLevels: ["B", "B", "C", "C", "D", "D"]
        },
        {
          organization: "ESC 2023",
          recommendations: [
            "Advise practicing regular low-to-moderate-intensity exercise in all able patients with cardiomyopathy.",
            "Obtain an individualized risk assessment for exercise prescription in all patients with cardiomyopathy.",
            "Consider allowing high-intensity exercise and competitive sport in genotype-positive/phenotype-negative patients seeking to do so.",
            "Consider allowing high-intensity exercise and competitive sport in asymptomatic low-risk patients with morphologically mild HCM in the absence of resting or inducible LV outflow obstruction and exercise-induced complex ventricular arrhythmias.",
            "Restrict high-intensity exercise, including competitive sport, in high-risk patients and in patients with LVOTO and exercise-induced complex ventricular arrhythmias."
          ],
          evidenceLevels: ["B", "B", "C", "C", "B"]
        }
      ]
    },
    {
      title: "Psychological support",
      evidenceLevel: "B",
      guidelines: [
        {
          organization: "ESC 2023",
          recommendations: [
            "Offer psychological support by an appropriately trained health professional in all patients with inherited cardiomyopathy receiving an implantable cardioverter defibrillator.",
            "Consider offering psychological support by an appropriately trained health professional in all patients and families with inherited cardiomyopathy.",
            "Offer psychological support by an appropriately trained health professional in all persons who have experienced the premature SCD of a family member with cardiomyopathy."
          ],
          evidenceLevels: ["B", "C", "B"]
        }
      ]
    }
  ]
}; 